Article Information
History
- October 14, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- David A Smith1,2,
- Daniel Bradshaw3,*,
- Jean Mbisa3,
- Carmen F Manso3,
- David Bibby3,
- Josh Singer4,
- Emma Thomson4,
- Ana Filipe4,
- Elihu Aranday-Cortes4,
- M. Azim Ansari1,
- Anthony Brown1,
- Emma Hudson1,
- Jennifer Benselin5,
- Brendan Healy6,
- Phil Troke7,
- STOP-HCV Consortium,
- HCV Research UK,
- John McLauchlan4,
- Eleanor Barnes1,2 and
- William L Irving5
- 1Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford
- 2NIHR Oxford Biomedical Research Centre
- 3National Infection Service, Public Health England
- 4MRC-University of Glasgow Centre for Virus Research, Glasgow G61 1QH
- 5NIHR Biomedical Research Centre (BRC), Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, UK
- 6Public Health Wales Microbiology Cardiff, University Hospital of Wales
- 7Gilead Sciences Ltd., London
- ↵*Corresponding Author: Daniel Bradshaw, National Infection Service, Public Health England, Colindale, 61 Colindale Avenue, London, NW9 5EQ. daniel.bradshaw{at}phe.gov.uk
Author Contributions: WLI lead this work. DAS, DB and JS performed the analysis and wrote the first draft of the manuscript. This work was supervised by JMc, EB and WLI. DB, JM, CFM, JB, ET, AF, EAC, MAA, AB, EH performed viral sequencing and contributed analysis tools. WLI, JM and JB collected clinical data. DAS, DB, JM, CFM, DB, JS, ET, AF, EAC, MAA, AB, EH, JB, BH, PT, JMc, EB, WLI provided significant edits and feedback on the manuscript.
Posted October 14, 2020.
Real World SOF/VEL/VOX Retreatment Outcomes and Viral Resistance Analysis for HCV Patients with Prior Failure to DAAs
